-
Incyte inks $750M deal for immune and neuro biotech Escient
23 Apr 2024 13:41 GMT
… million to buy San Diego biotech Escient Pharmaceuticals and its pipeline … deal gives the Delaware-based drugmaker access to once-daily oral …
-
10 Best Performing Biotech ETFs in 2024
22 Apr 2024 15:24 GMT
… companies within two sub-industries: Biotech Therapeutics, focused on therapeutic … , marketing, and distribution of biotechnological products and services. As of … , Inc. (NYSE:NBIX), a pharmaceutical company dedicated to discovering, developing, and …
-
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
23 Apr 2024 12:30 GMT
– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to redefine UC treatment through targeted interventions based on PDE4- …
-
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
23 Apr 2024 11:30 GMT
BASKING RIDGE, N.J. and JINAN, China, April 23, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid …
-
Better Buy: Pfizer vs. Viking Therapeutics
23 Apr 2024 13:46 GMT
… landscape, some early stage biotech firms have still managed to … same time, several big pharma companies continue to offer attractive valuations … income.
So, is the drugmaker';s sky-high dividend … different from many other pharma companies who rely on one or …
-
Baron Health Care Fund Q1 2024 Shareholder Letter
23 Apr 2024 14:48 GMT
… and Company is a global pharmaceutical company that discovers, develops, manufactures, … high-growth companies, and biotechnology companies. We define earnings … headwinds including customer destocking, biotechnology customer funding constraints, and …
-
Danaher Corporation (DHR) Q1 2024 Earnings Call Transcript
23 Apr 2024 14:48 GMT
… offset by declines in biotechnology. High growth markets declined … Core revenue in our Biotechnology segment declined 17%, with … is a business where pharmaceutical companies need to minimize and … to be seen as pharmaceutical companies perhaps search for other …
-
Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results
23 Apr 2024 14:48 GMT
… a pure-play, high-margin pharma company with a strong pipeline and … stocks, with a focus on biotech, consider signing up. We focus …
-
NantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive Team
23 Apr 2024 13:25 GMT
… the healthcare, pharmaceutical, and biotechnology industries. Prior to joining NantHealth … officer at Legend Biotech, a publicly traded biotechnology company, and served … Pharmaceutical, a privately held pharmaceutical company.
With a background that …
-
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
23 Apr 2024 12:55 GMT
… creating a diversified portfolio of biotech and pharmaceutical product revenue streams … in the promise of the biotech industry in a profitable and … with the world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz …